Skip Header

Contribute Send feedback
Read comments (?) or add your own

Q8NDV7 (TNR6A_HUMAN) Reviewed, UniProtKB/Swiss-Prot

Last modified January 25, 2012. Version 94. Feed History...

Clusters with 100%, 90%, 50% identity | Documents (5) | Third-party data text xml rdf/xml gff fasta
to top of pageNames·Attributes·General annotation·Ontologies·Alt products·Sequence annotation·Sequences·References·Cross-refs·Entry info·DocumentsCustomize order

Names and origin

Protein namesRecommended name:
Trinucleotide repeat-containing gene 6A protein
Alternative name(s):
CAG repeat protein 26
EMSY interactor protein
GW182 autoantigen
Short name=Protein GW1
Glycine-tryptophan protein of 182 kDa
Gene names
Name:TNRC6A
Synonyms:CAGH26, KIAA1460, TNRC6
OrganismHomo sapiens (Human)
Taxonomic identifier9606 [NCBI]
Taxonomic lineageEukaryotaMetazoaChordataCraniataVertebrataEuteleostomiMammaliaEutheriaEuarchontogliresPrimatesHaplorrhiniCatarrhiniHominidaeHomo

Protein attributes

Sequence length1962 AA.
Sequence statusComplete.
Protein existenceEvidence at protein level

General annotation (Comments)

Function

Plays a role in RNA-mediated gene silencing by both micro-RNAs (miRNAs) and short interfering RNAs (siRNAs). Required for miRNA-dependent repression of translation and for siRNA-dependent endonucleolytic cleavage of complementary mRNAs by argonaute family proteins. Ref.13 Ref.14 Ref.17 Ref.19 Ref.21 Ref.25

Subunit structure

Interacts with EIF2C1/AGO1, EIF2C2/AGO2, EIF2C3/AGO3 and EIF2C4/AGO4. Ref.13 Ref.14 Ref.22 Ref.25 Ref.26

Subcellular location

CytoplasmP-body. Note: Mammalian P-bodies are also known as GW bodies (GWBs). Ref.1 Ref.10 Ref.11 Ref.12 Ref.13 Ref.14 Ref.16 Ref.21 Ref.24 Ref.26

Tissue specificity

Ubiquitous. Ref.1

Induction

By exogenous short interfering RNA (siRNA). Ref.24

Miscellaneous

Antibodies against TNRC6A are found in sera from patients with Sjoegren syndrome (SS), ataxia and sensor neuropathy diseases that developed autoantibodies against protein of the GWB structure. Autoantibodies were mapped to the GW-rich mid-part, the non-GW-rich region and the C-terminus of the protein.

Sequence similarities

Belongs to the GW182 family.

Contains 1 RRM (RNA recognition motif) domain.

Sequence caution

The sequence BAA91899.1 differs from that shown. Reason: Erroneous initiation. Translation N-terminally extended.

The sequence CAD28525.2 differs from that shown. Reason: Erroneous initiation. Translation N-terminally shortened.

Alternative products

This entry describes 6 isoforms produced by alternative splicing. [Align] [Select]
Isoform 1 (identifier: Q8NDV7-1)

Also known as: TNGW1;

This isoform has been chosen as the 'canonical' sequence. All positional information in this entry refers to it. This is also the sequence that appears in the downloadable versions of the entry.
Isoform 2 (identifier: Q8NDV7-2)

The sequence of this isoform differs from the canonical sequence as follows:
     1-253: Missing.
Isoform 3 (identifier: Q8NDV7-3)

The sequence of this isoform differs from the canonical sequence as follows:
     1-1232: Missing.
     1280-1328: Missing.
     1611-1962: Missing.
Isoform 4 (identifier: Q8NDV7-4)

The sequence of this isoform differs from the canonical sequence as follows:
     1-1801: Missing.
Isoform 5 (identifier: Q8NDV7-5)

The sequence of this isoform differs from the canonical sequence as follows:
     1-54: MRELEAKATK...QKKATEQKIK → MAYFGGTLYWLIFSTPFLLLGL
Note: No experimental confirmation available.
Isoform 6 (identifier: Q8NDV7-6)

The sequence of this isoform differs from the canonical sequence as follows:
     1280-1328: Missing.

Sequence annotation (Features)

Feature keyPosition(s)LengthDescriptionGraphical viewFeature identifier

Molecule processing

Chain1 – 19621962Trinucleotide repeat-containing gene 6A protein
PRO_0000081980

Regions

Domain1781 – 185373RRM
Region254 – 503250Sufficient for interaction with EIF2C1, EIF2C3 and EIF2C4
Region270 – 34677Sufficient for interaction with EIF2C2
Region318 – 39982Sufficient for interaction with EIF2C2
Region340 – 439100Sufficient for interaction with EIF2C2
Region409 – 49587Sufficient for interaction with EIF2C2
Region502 – 751250Sufficient for interaction with EIF2C2
Region566 – 1343778Sufficient for interaction with EIF2C1 and EIF2C4
Region1074 – 114471Sufficient for interaction with EIF2C2
Region1670 – 1962293Sufficient for interaction with EIF2C2
Coiled coil7 – 5448 Potential
Compositional bias93 – 12735Gln-rich
Compositional bias192 – 365174Ser-rich

Amino acid modifications

Modified residue9911Phosphoserine By similarity
Modified residue14701Phosphothreonine Ref.23
Modified residue15851Phosphoserine Ref.27

Natural variations

Alternative sequence1 – 18011801Missing in isoform 4.
VSP_013292
Alternative sequence1 – 12321232Missing in isoform 3.
VSP_037287
Alternative sequence1 – 253253Missing in isoform 2.
VSP_013294
Alternative sequence1 – 5454MRELE…EQKIK → MAYFGGTLYWLIFSTPFLLL GL in isoform 5.
VSP_013295
Alternative sequence1280 – 132849Missing in isoform 3 and isoform 6.
VSP_037288
Alternative sequence1611 – 1962352Missing in isoform 3.
VSP_037289
Natural variant1851N → K.
Corresponds to variant rs11639856 [ dbSNP | Ensembl ].
VAR_057251
Natural variant5921A → T.
Corresponds to variant rs6497759 [ dbSNP | Ensembl ].
VAR_057252
Natural variant7881P → S.
Corresponds to variant rs3803716 [ dbSNP | Ensembl ].
VAR_057253
Natural variant12681E → K.
Corresponds to variant rs2112782 [ dbSNP | Ensembl ].
VAR_057254

Experimental info

Mutagenesis3131W → A: Does not impair interaction with EIF2C2; when associated with A-345; A-370; A-420 and A-483. Ref.26
Mutagenesis3451W → A: Does not impair interaction with EIF2C2; when associated with A-313; A-370; A-420 and A-483. Ref.26
Mutagenesis3701W → A: Does not impair interaction with EIF2C2; when associated with A-313; A-345; A-420 and A-483. Ref.26
Mutagenesis4201W → A: Does not impair interaction with EIF2C2; when associated with A-313; A-345; A-370 and A-483. Ref.26
Mutagenesis4831W → A: Does not impair interaction with EIF2C2; when associated with A-313; A-345; A-370 and A-420. Ref.26
Sequence conflict31 – 344KKKK → TEKE in CAD37348. Ref.2
Sequence conflict13751V → VV in CAD28525. Ref.3
Sequence conflict17041S → F in BAA91899. Ref.8

Sequences

Sequence LengthMass (Da)Tools
Isoform 1 (TNGW1) [UniParc].

Last modified May 18, 2010. Version 2.
Checksum: 963C054628E18592

FASTA1,962210,297
        10         20         30         40         50         60 
MRELEAKATK DVERNLSRDL VQEEEQLMEE KKKKKDDKKK KEAAQKKATE QKIKVPEQIK 

        70         80         90        100        110        120 
PSVSQPQPAN SNNGTSTATS TNNNAKRATA NNQQPQQQQQ QQQPQQQQPQ QQPQPQPQQQ 

       130        140        150        160        170        180 
QPQQQPQALP RYPREVPPRF RHQEHKQLLK RGQHFPVIAA NLGSAVKVLN SQSESSALTN 

       190        200        210        220        230        240 
QQPQNNGEVQ NSKNQSDINH STSGSHYENS QRGPVSSTSD SSTNCKNAVV SDLSEKEAWP 

       250        260        270        280        290        300 
SAPGSDPELA SECMDADSAS SSESERNITI MASGNTGGEK DGLRNSTGLG SQNKFVVGSS 

       310        320        330        340        350        360 
SNNVGHGSST GPWGFSHGAI ISTCQVSVDA PESKSESSNN RMNAWGTVSS SSNGGLNPST 

       370        380        390        400        410        420 
LNSASNHGAW PVLENNGLAL KGPVGSGSSG INIQCSTIGQ MPNNQSINSK VSGGSTHGTW 

       430        440        450        460        470        480 
GSLQETCESE VSGTQKVSFS GQPQNITTEM TGPNNTTNFM TSSLPNSGSV QNNELPSSNT 

       490        500        510        520        530        540 
GAWRVSTMNH PQMQAPSGMN GTSLSHLSNG ESKSGGSYGT TWGAYGSNYS GDKCSGPNGQ 

       550        560        570        580        590        600 
ANGDTVNATL MQPGVNGPMG TNFQVNTNKG GGVWESGAAN SQSTSWGSGN GANSGGSRRG 

       610        620        630        640        650        660 
WGTPAQNTGT NLPSVEWNKL PSNQHSNDSA NGNGKTFTNG WKSTEEEDQG SATSQTNEQS 

       670        680        690        700        710        720 
SVWAKTGGTV ESDGSTESTG RLEEKGTGES QSRDRRKIDQ HTLLQSIVNR TDLDPRVLSN 

       730        740        750        760        770        780 
SGWGQTPIKQ NTAWDTETSP RGERKTDNGT EAWGSSATQT FNSGACIDKT SPNGNDTSSV 

       790        800        810        820        830        840 
SGWGDPKPAL RWGDSKGSNC QGGWEDDSAA TGMVKSNQWG NCKEEKAAWN DSQKNKQGWG 

       850        860        870        880        890        900 
DGQKSSQGWS VSASDNWGET SRNNHWGEAN KKSSSGGSDS DRSVSGWNEL GKTSSFTWGN 

       910        920        930        940        950        960 
NINPNNSSGW DESSKPTPSQ GWGDPPKSNQ SLGWGDSSKP VSSPDWNKQQ DIVGSWGIPP 

       970        980        990       1000       1010       1020 
ATGKPPGTGW LGGPIPAPAK EEEPTGWEEP SPESIRRKME IDDGTSAWGD PSKYNYKNVN 

      1030       1040       1050       1060       1070       1080 
MWNKNVPNGN SRSDQQAQVH QLLTPASAIS NKEASSGSGW GEPWGEPSTP ATTVDNGTSA 

      1090       1100       1110       1120       1130       1140 
WGKPIDSGPS WGEPIAAASS TSTWGSSSVG PQALSKSGPK SMQDGWCGDD MPLPGNRPTG 

      1150       1160       1170       1180       1190       1200 
WEEEEDVEIG MWNSNSSQEL NSSLNWPPYT KKMSSKGLSG KKRRRERGMM KGGNKQEEAW 

      1210       1220       1230       1240       1250       1260 
INPFVKQFSN ISFSRDSPEE NVQSNKMDLS GGMLQDKRME IDKHSLNIGD YNRTVGKGPG 

      1270       1280       1290       1300       1310       1320 
SRPQISKESS MERNPYFDKD GIVADESQNM QFMSSQSMKL PPSNSALPNQ ALGSIAGLGM 

      1330       1340       1350       1360       1370       1380 
QNLNSVRQNG NPSMFGVGNT AAQPRGMQQP PAQPLSSSQP NLRAQVPPPL LSPQVPVSLL 

      1390       1400       1410       1420       1430       1440 
KYAPNNGGLN PLFGPQQVAM LNQLSQLNQL SQISQLQRLL AQQQRAQSQR SVPSGNRPQQ 

      1450       1460       1470       1480       1490       1500 
DQQGRPLSVQ QQMMQQSRQL DPNLLVKQQT PPSQQQPLHQ PAMKSFLDNV MPHTTPELQK 

      1510       1520       1530       1540       1550       1560 
GPSPINAFSN FPIGLNSNLN VNMDMNSIKE PQSRLRKWTT VDSISVNTSL DQNSSKHGAI 

      1570       1580       1590       1600       1610       1620 
SSGFRLEESP FVPYDFMNSS TSPASPPGSI GDGWPRAKSP NGSSSVNWPP EFRPGEPWKG 

      1630       1640       1650       1660       1670       1680 
YPNIDPETDP YVTPGSVINN LSINTVREVD HLRDRNSGSS SSLNTTLPST SAWSSIRASN 

      1690       1700       1710       1720       1730       1740 
YNVPLSSTAQ STSARNSDSK LTWSPGSVTN TSLAHELWKV PLPPKNITAP SRPPPGLTGQ 

      1750       1760       1770       1780       1790       1800 
KPPLSTWDNS PLRIGGGWGN SDARYTPGSS WGESSSGRIT NWLVLKNLTP QIDGSTLRTL 

      1810       1820       1830       1840       1850       1860 
CMQHGPLITF HLNLPHGNAL VRYSSKEEVV KAQKSLHMCV LGNTTILAEF ASEEEISRFF 

      1870       1880       1890       1900       1910       1920 
AQSQSLTPSP GWQSLGSSQS RLGSLDCSHS FSSRTDLNHW NGAGLSGTNC GDLHGTSLWG 

      1930       1940       1950       1960 
TPHYSTSLWG PPSSSDPRGI SSPSPINAFL SVDHLGGGGE SM 

« Hide

Isoform 2 [UniParc].

Checksum: 6CCAC36D8FE45088
Show »

FASTA1,709182,053
Isoform 3 [UniParc].

Checksum: 4A18C3669378FF04
Show »

FASTA32936,154
Isoform 4 [UniParc].

Checksum: 2725AD138B814BCE
Show »

FASTA16117,151
Isoform 5 [UniParc].

Checksum: 24936EA0AD526EB1
Show »

FASTA1,930206,363
Isoform 6 [UniParc].

Checksum: 3F1228974880B3E2
Show »

FASTA1,913205,151

References

« Hide 'large scale' references
[1]"A phosphorylated cytoplasmic autoantigen, GW182, associates with a unique population of human mRNAs within novel cytoplasmic speckles."
Eystathioy T., Chan E.K.L., Tenenbaum S.A., Keene J.D., Griffith K., Fritzler M.J.
Mol. Biol. Cell 13:1338-1351(2002) [PubMed: 11950943] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2), RNA-BINDING, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, PHOSPHORYLATION.
Tissue: Cervix carcinoma.
[2]"Candidate EMSY interactor protein."
Hughes-Davies L.
Submitted (JUN-2002) to the EMBL/GenBank/DDBJ databases
Cited for: NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
[3]"The full-ORF clone resource of the German cDNA consortium."
Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U., Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D., Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A., Wiemann S., Schupp I.
BMC Genomics 8:399-399(2007) [PubMed: 17974005] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 861-1962 (ISOFORM 6).
Tissue: Kidney and Stomach.
[4]"The sequence and analysis of duplication-rich human chromosome 16."
Martin J., Han C., Gordon L.A., Terry A., Prabhakar S., She X., Xie G., Hellsten U., Chan Y.M., Altherr M., Couronne O., Aerts A., Bajorek E., Black S., Blumer H., Branscomb E., Brown N.C., Bruno W.J. expand/collapse author list , Buckingham J.M., Callen D.F., Campbell C.S., Campbell M.L., Campbell E.W., Caoile C., Challacombe J.F., Chasteen L.A., Chertkov O., Chi H.C., Christensen M., Clark L.M., Cohn J.D., Denys M., Detter J.C., Dickson M., Dimitrijevic-Bussod M., Escobar J., Fawcett J.J., Flowers D., Fotopulos D., Glavina T., Gomez M., Gonzales E., Goodstein D., Goodwin L.A., Grady D.L., Grigoriev I., Groza M., Hammon N., Hawkins T., Haydu L., Hildebrand C.E., Huang W., Israni S., Jett J., Jewett P.B., Kadner K., Kimball H., Kobayashi A., Krawczyk M.-C., Leyba T., Longmire J.L., Lopez F., Lou Y., Lowry S., Ludeman T., Manohar C.F., Mark G.A., McMurray K.L., Meincke L.J., Morgan J., Moyzis R.K., Mundt M.O., Munk A.C., Nandkeshwar R.D., Pitluck S., Pollard M., Predki P., Parson-Quintana B., Ramirez L., Rash S., Retterer J., Ricke D.O., Robinson D.L., Rodriguez A., Salamov A., Saunders E.H., Scott D., Shough T., Stallings R.L., Stalvey M., Sutherland R.D., Tapia R., Tesmer J.G., Thayer N., Thompson L.S., Tice H., Torney D.C., Tran-Gyamfi M., Tsai M., Ulanovsky L.E., Ustaszewska A., Vo N., White P.S., Williams A.L., Wills P.L., Wu J.-R., Wu K., Yang J., DeJong P., Bruce D., Doggett N.A., Deaven L., Schmutz J., Grimwood J., Richardson P., Rokhsar D.S., Eichler E.E., Gilna P., Lucas S.M., Myers R.M., Rubin E.M., Pennacchio L.A.
Nature 432:988-994(2004) [PubMed: 15616553] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
[5]"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)."
The MGC Project Team
Genome Res. 14:2121-2127(2004) [PubMed: 15489334] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 4), NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1515-1962.
Tissue: Kidney and PNS.
[6]"cDNAs with long CAG trinucleotide repeats from human brain."
Margolis R.L., Abraham M.R., Gatchell S.B., Li S.-H., Kidwai A.S., Breschel T.S., Stine O.C., Callahan C., McInnis M.G., Ross C.A.
Hum. Genet. 100:114-122(1997) [PubMed: 9225980] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 1-157 (ISOFORM 5).
Tissue: Brain.
[7]"Prediction of the coding sequences of unidentified human genes. XVII. The complete sequences of 100 new cDNA clones from brain which code for large proteins in vitro."
Nagase T., Kikuno R., Ishikawa K., Hirosawa M., Ohara O.
DNA Res. 7:143-150(2000) [PubMed: 10819331] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 565-1962.
Tissue: Brain.
[8]"Complete sequencing and characterization of 21,243 full-length human cDNAs."
Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R., Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H., Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S. expand/collapse author list , Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K., Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S., Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O., Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H., Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B., Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.
Nat. Genet. 36:40-45(2004) [PubMed: 14702039] [Abstract]
Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 1522-1962.
Tissue: Ovarian carcinoma.
[9]"Clinical and serological associations of autoantibodies to GW bodies and a novel cytoplasmic autoantigen GW182."
Eystathioy T., Chan E.K.L., Takeuchi K., Mahler M., Luft L.M., Zochodne D.W., Fritzler M.J.
J. Mol. Med. 81:811-818(2003) [PubMed: 14598044] [Abstract]
Cited for: AUTOANTIGENIC EPITOPE MAPPING.
[10]"The GW182 protein colocalizes with mRNA degradation associated proteins hDcp1 and hLSm4 in cytoplasmic GW bodies."
Eystathioy T., Jakymiw A., Chan E.K.L., Seraphin B., Cougot N., Fritzler M.J.
RNA 9:1171-1173(2003) [PubMed: 13130130] [Abstract]
Cited for: SUBCELLULAR LOCATION.
[11]"GW182 is critical for the stability of GW bodies expressed during the cell cycle and cell proliferation."
Yang Z., Jakymiw A., Wood M.R., Eystathioy T., Rubin R.L., Fritzler M.J., Chan E.K.L.
J. Cell Sci. 117:5567-5578(2004) [PubMed: 15494374] [Abstract]
Cited for: SUBCELLULAR LOCATION.
[12]"Argonaute 2/RISC resides in sites of mammalian mRNA decay known as cytoplasmic bodies."
Sen G.L., Blau H.M.
Nat. Cell Biol. 7:633-636(2005) [PubMed: 15908945] [Abstract]
Cited for: SUBCELLULAR LOCATION.
[13]"A role for the P-body component GW182 in microRNA function."
Liu J., Rivas F.V., Wohlschlegel J., Yates J.R. III, Parker R., Hannon G.J.
Nat. Cell Biol. 7:1261-1266(2005) [PubMed: 16284623] [Abstract]
Cited for: FUNCTION, INTERACTION WITH EIF2C2, SUBCELLULAR LOCATION.
[14]"Disruption of GW bodies impairs mammalian RNA interference."
Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C., Fritzler M.J., Chan E.K.L.
Nat. Cell Biol. 7:1267-1274(2005) [PubMed: 16284622] [Abstract]
Cited for: FUNCTION, INTERACTION WITH EIF2C2, ASSOCIATION WITH SIRNA, SUBCELLULAR LOCATION.
[15]Erratum
Jakymiw A., Lian S.L., Eystathioy T., Li S., Satoh M., Hamel J.C., Fritzler M.J., Chan E.K.L.
Nat. Cell Biol. 8:100-100(2006)
[16]"Formation of GW bodies is a consequence of microRNA genesis."
Pauley K.M., Eystathioy T., Jakymiw A., Hamel J.C., Fritzler M.J., Chan E.K.L.
EMBO Rep. 7:904-910(2006) [PubMed: 16906129] [Abstract]
Cited for: SUBCELLULAR LOCATION, ASSOCIATION WITH MICRORNA.
[17]"Let-7 microRNA-mediated mRNA deadenylation and translational repression in a mammalian cell-free system."
Wakiyama M., Takimoto K., Ohara O., Yokoyama S.
Genes Dev. 21:1857-1862(2007) [PubMed: 17671087] [Abstract]
Cited for: FUNCTION.
[18]Erratum
Wakiyama M., Takimoto K., Ohara O., Yokoyama S.
Genes Dev. 21:2509-2509(2007)
[19]"Small interfering RNA-mediated silencing induces target-dependent assembly of GW/P bodies."
Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M., Chan E.K.L.
Mol. Biol. Cell 18:3375-3387(2007) [PubMed: 17596515] [Abstract]
Cited for: FUNCTION.
[20]Erratum
Lian S.L., Fritzler M.J., Katz J., Hamazaki T., Terada N., Satoh M., Chan E.K.L.
Mol. Biol. Cell 18:4200-4200(2007)
[21]"Identification of GW182 and its novel isoform TNGW1 as translational repressors in Ago2-mediated silencing."
Li S., Lian S.L., Moser J.J., Fritzler M.L., Fritzler M.J., Satoh M., Chan E.K.L.
J. Cell Sci. 121:4134-4144(2008) [PubMed: 19056672] [Abstract]
Cited for: FUNCTION, SUBCELLULAR LOCATION.
[22]"Prolyl 4-hydroxylation regulates Argonaute 2 stability."
Qi H.H., Ongusaha P.P., Myllyharju J., Cheng D., Pakkanen O., Shi Y., Lee S.W., Peng J., Shi Y.
Nature 455:421-424(2008) [PubMed: 18690212] [Abstract]
Cited for: IDENTIFICATION BY MASS SPECTROMETRY, INTERACTION WITH EIF2C2.
[23]"A quantitative atlas of mitotic phosphorylation."
Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E., Elledge S.J., Gygi S.P.
Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008) [PubMed: 18669648] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-1470, MASS SPECTROMETRY.
Tissue: Cervix carcinoma.
[24]"Localization of double-stranded small interfering RNA to cytoplasmic processing bodies is Ago2 dependent and results in up-regulation of GW182 and Argonaute-2."
Jagannath A., Wood M.J.A.
Mol. Biol. Cell 20:521-529(2009) [PubMed: 18946079] [Abstract]
Cited for: SUBCELLULAR LOCATION, INDUCTION.
[25]"Importance of the C-terminal domain of the human GW182 protein TNRC6C for translational repression."
Zipprich J.T., Bhattacharyya S., Mathys H., Filipowicz W.
RNA 15:781-793(2009) [PubMed: 19304925] [Abstract]
Cited for: FUNCTION, INTERACTION WITH EIF2C2.
[26]"The C-terminal half of human Ago2 binds to multiple GW-rich regions of GW182 and requires GW182 to mediate silencing."
Lian S.L., Li S., Abadal G.X., Pauley B.A., Fritzler M.J., Chan E.K.L.
RNA 15:804-813(2009) [PubMed: 19324964] [Abstract]
Cited for: INTERACTION WITH EIF2C1; EIF2C2; EIF2C3 AND EIF2C4, SUBCELLULAR LOCATION, MUTAGENESIS OF TRP-313; TRP-345; TRP-370; TRP-420 AND TRP-483.
[27]"Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions."
Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K., Rodionov V., Han D.K.
Sci. Signal. 2:RA46-RA46(2009) [PubMed: 19690332] [Abstract]
Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-1585, MASS SPECTROMETRY.
Tissue: Leukemic T-cell.
+Additional computationally mapped references.

Cross-references

Sequence databases

EMBL
GenBank
DDBJ
AY035864 mRNA. Translation: AAK62026.1.
AJ492221 mRNA. Translation: CAD37348.1.
AL713750 mRNA. Translation: CAD28525.2. Different initiation.
AL833757 mRNA. Translation: CAH56236.1.
AC002565 Genomic DNA. No translation available.
AC008731 Genomic DNA. No translation available.
BC024324 mRNA. Translation: AAH24324.2.
BC068209 mRNA. No translation available.
U80739 mRNA. Translation: AAB91438.1.
AB040893 mRNA. Translation: BAA95984.1.
AK001773 mRNA. Translation: BAA91899.1. Different initiation.
IPIIPI00160265.
IPI00382618.
IPI00395878.
IPI00554606.
IPI00554721.
IPI00853634.
RefSeqNP_055309.2. NM_014494.2.
UniGeneHs.655057.

3D structure databases

ProteinModelPortalQ8NDV7.
SMRQ8NDV7. Positions 1186-1258, 1774-1862.
ModBaseSearch...

Protein-protein interaction databases

IntActQ8NDV7. 31 interactions.
STRINGQ8NDV7.

PTM databases

PhosphoSiteQ8NDV7.

Polymorphism databases

DMDM296452846.

Proteomic databases

PRIDEQ8NDV7.

Protocols and materials databases

StructuralBiologyKnowledgebaseSearch...

Genome annotation databases

EnsemblENST00000395799; ENSP00000379144; ENSG00000090905.
GeneID27327.
KEGGhsa:27327.
UCSCuc002dmm.1. human.
uc002dmn.1. human.
uc002dmr.1. human.

Organism-specific databases

CTD27327.
GeneCardsGC16P024741.
H-InvDBHIX0012904.
HGNCHGNC:11969. TNRC6A.
HPAHPA015305.
HPA017869.
MIM610739. gene.
neXtProtNX_Q8NDV7.
PharmGKBPA36656.
HUGESearch...
GenAtlasSearch...

Phylogenomic databases

eggNOGprNOG05635.
GeneTreeENSGT00410000025966.
HOVERGENHBG062594.
InParanoidQ8NDV7.
OMAWGDSKGS.

Gene expression databases

ArrayExpressQ8NDV7.
BgeeQ8NDV7.
GenevestigatorQ8NDV7.
GermOnlineENSG00000090905. Homo sapiens.

Family and domain databases

InterProIPR019486. Argonaute_hook_dom.
IPR012677. Nucleotide-bd_a/b_plait.
IPR000504. RRM_dom.
IPR009060. UBA-like.
[Graphical view]
Gene3DG3DSA:3.30.70.330. a_b_plait_nuc_bd. 1 hit.
PfamPF10427. Ago_hook. 1 hit.
[Graphical view]
SMARTSM00360. RRM. 1 hit.
[Graphical view]
SUPFAMSSF46934. UBA_like. 1 hit.
PROSITEPS50102. RRM. False negative.
[Graphical view]
ProtoNetSearch...

Other

NextBio50354.
SOURCESearch...

Entry information

Entry nameTNR6A_HUMAN
AccessionPrimary (citable) accession number: Q8NDV7
Secondary accession number(s): C9JAR8 expand/collapse secondary AC list , O15408, Q658L5, Q6NVB5, Q8NEZ0, Q8TBT8, Q8TCR0, Q9NV59, Q9P268
Entry history
Integrated into UniProtKB/Swiss-Prot: March 29, 2005
Last sequence update: May 18, 2010
Last modified: January 25, 2012
This is version 94 of the entry and version 2 of the sequence. [Complete history]
Entry statusReviewed (UniProtKB/Swiss-Prot)
Annotation programChordata Protein Annotation Program
DisclaimerAny medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care.

Relevant documents

Human chromosome 16

Human chromosome 16: entries, gene names and cross-references to MIM

Human entries with polymorphisms or disease mutations

List of human entries with polymorphisms or disease mutations

Human polymorphisms and disease mutations

Index of human polymorphisms and disease mutations

MIM cross-references

Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot

SIMILARITY comments

Index of protein domains and families